MeSH Browser

MeSH Heading: Tenofovir
Tree Number(s): D02.705.429.906; D03.633.100.759.138.881
Unique ID: D000068698
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000068698
Scope Note: An adenine analog REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone.
Entry Term(s): (R)-9-(2-phosphonylmethoxypropyl)adenine; 9-(2-Phosphonomethoxypropyl)adenine; 9-(2-Phosphonylmethoxypropyl)adenine; 9-(2-Phosphonylmethoxypropyl)adenine, (+-)-isomer; 9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098; 9-(2-Phosphonylmethoxypropyl)adenine, (S)-isomer; 9-PMPA (tenofovir); Tenofovir Disoproxil; Tenofovir Disoproxil Fumarate; Viread
Pharm Action: Antiviral Agents
Reverse Transcriptase Inhibitors
Anti-HIV Agents
Related Numbers: 121149-89-1; 147127-19-3; 147127-20-6; F4YU4LON7I; OTT9J7900I
Public MeSH Note: 2016; TENOFOVIR DIDOPROXIL was indexed under ORGANOPHOSPHONATES 2004-2015, ADENINE 2004-2015, and under ORGANOPHOSPHOROUS COMPOUNDS 2001-2004
History Note: 2016 (2001)
Date Established: 2016/01/01
Date of Entry: 2015/07/09
Revision Date: 2016/07/05

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Tenofovir MeSH Descriptor Data 2024